Search research articles
Contact Us
Filters
Showing results (171-180 of 194) with videos related to
Page
of 20
Sort By:
Clinical Pharmacology and Therapeutics
|
September 23, 2020
Impaired Clearance From the Brain Increases the Brain Exposure to Metoclopramide in Elderly Subjects
Martin Bauer, Karsten Bamminger, Verena Pichler, et al.
Pharmaceutics
|
December 23, 2022
Impact of Cytochrome Induction or Inhibition on the Plasma and Brain Kinetics of [<sup>11</sup>C]metoclopramide, a PET Probe for P-Glycoprotein Function at the Blood-Brain Barrier
Louise Breuil, Nora Ziani, Sarah Leterrier, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 30, 2020
Impact of blood-brain barrier permeabilization induced by ultrasound associated to microbubbles on the brain delivery and kinetics of cetuximab: An immunoPET study using <sup>89</sup>Zr-cetuximab
Vu Long Tran, Anthony Novell, Nicolas Tournier, et al.
Molecular Psychiatry
|
November 18, 2025
Quantitative monitoring of ketamine's impact on synaptic density using <sup>11</sup>C-UCB-J PET imaging in the corticosterone mouse model of anxiety/depression
Cassandre Corvo, Sébastien Goutal, Indira Mendez-David, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
September 11, 2021
Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patients
Olivier Bylicki, David Delarbre, Aurélie Mayet, et al.
Advanced Healthcare Materials
|
July 2, 2021
Quantitative Tissue Pharmacokinetics and EPR Effect of AGuIX Nanoparticles: A Multimodal Imaging Study in an Orthotopic Glioblastoma Rat Model and Healthy Macaque
Vu-Long Tran, François Lux, Nicolas Tournier, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 24, 2024
Successful repositioning of mertansine for improved chemotherapy by combining a polymer prodrug approach and PET imaging
Soizic Martin-Aubert, Kevin Avrillon, Nicolas Tournier, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
October 21, 2020
Complete inhibition of ABCB1 and ABCG2 at the blood-brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [<sup>11</sup>C]erlotinib
Nicolas Tournier, Sebastien Goutal, Severin Mairinger, et al.
Scientific Reports
|
November 7, 2019
Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model
Gwenaëlle Le Roux, Rafika Jarray, Anne-Cécile Guyot, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 11, 2025
Corrigendum to "Enhancing oxime efficacy into brain using ultrasound to counteract nerve agent exposure" [Biomed. Pharmacother. 187 (2025) 118120]
Lucie Lépinard, Sarah Leterrier, Laurène Jourdain, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 194) with videos related to
Sort By:
Page
of 20
Clinical Pharmacology and Therapeutics
|
September 23, 2020
Impaired Clearance From the Brain Increases the Brain Exposure to Metoclopramide in Elderly Subjects
Martin Bauer, Karsten Bamminger, Verena Pichler, et al.
Pharmaceutics
|
December 23, 2022
Impact of Cytochrome Induction or Inhibition on the Plasma and Brain Kinetics of [<sup>11</sup>C]metoclopramide, a PET Probe for P-Glycoprotein Function at the Blood-Brain Barrier
Louise Breuil, Nora Ziani, Sarah Leterrier, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 30, 2020
Impact of blood-brain barrier permeabilization induced by ultrasound associated to microbubbles on the brain delivery and kinetics of cetuximab: An immunoPET study using <sup>89</sup>Zr-cetuximab
Vu Long Tran, Anthony Novell, Nicolas Tournier, et al.
Molecular Psychiatry
|
November 18, 2025
Quantitative monitoring of ketamine's impact on synaptic density using <sup>11</sup>C-UCB-J PET imaging in the corticosterone mouse model of anxiety/depression
Cassandre Corvo, Sébastien Goutal, Indira Mendez-David, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
September 11, 2021
Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patients
Olivier Bylicki, David Delarbre, Aurélie Mayet, et al.
Advanced Healthcare Materials
|
July 2, 2021
Quantitative Tissue Pharmacokinetics and EPR Effect of AGuIX Nanoparticles: A Multimodal Imaging Study in an Orthotopic Glioblastoma Rat Model and Healthy Macaque
Vu-Long Tran, François Lux, Nicolas Tournier, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 24, 2024
Successful repositioning of mertansine for improved chemotherapy by combining a polymer prodrug approach and PET imaging
Soizic Martin-Aubert, Kevin Avrillon, Nicolas Tournier, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
October 21, 2020
Complete inhibition of ABCB1 and ABCG2 at the blood-brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [<sup>11</sup>C]erlotinib
Nicolas Tournier, Sebastien Goutal, Severin Mairinger, et al.
Scientific Reports
|
November 7, 2019
Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model
Gwenaëlle Le Roux, Rafika Jarray, Anne-Cécile Guyot, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 11, 2025
Corrigendum to "Enhancing oxime efficacy into brain using ultrasound to counteract nerve agent exposure" [Biomed. Pharmacother. 187 (2025) 118120]
Lucie Lépinard, Sarah Leterrier, Laurène Jourdain, et al.
Page
of 20